FDA recall record

Bomunity Ltd Co Paximune Dietary Supplement Contains Bovine Proteins that help recall — FDA F-0817-2021

Potential to be contaminated with bacteria

Class IIclassification
F-0817-2021official record ID
Aug 11, 2021report date

Recall record at a glance

Official recordF-0817-2021
CategoryFood Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmBomunity Ltd Co
Report dateAug 11, 2021
Recall initiation dateJun 4, 2021
Quantity3540 cases
LocationAmarillo, TX, United States

Official product description

Paximune Dietary Supplement Contains Bovine Proteins that help Promote Health and help Modulate Immunity 2 Fl. Oz. (60ml) packaged in dark glass bottle 12 bottles per case UPC 64395 00001

Why the product was recalled

Potential to be contaminated with bacteria

Distribution information

Nationwide throughout the US

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.